HeartSciences Inc. (NASDAQ:HSCS) Posts Wider FQ1 Loss; Fortitude Deal on Track

HeartSciences reported FQ1 2027 net loss of $3.2M vs $2.1M and no meaningful revenue. The Fortitude merger is expected to close in Q4 2026, subject to conditions.Material DetailsContext by AI AnalystThis is early-stage confirmation of ongoing losses while pivoting to a software platform and pursuin…